Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Dose on Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vaccine in Adults With Previous Smallpox Vaccination

NCT00053482 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT00053482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00053482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Dose on Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vaccine in Adults With Previous Smallpox Vaccination
Lead sponsor
Emergent BioSolutions
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2003
Completion date
October 31, 2003
Enrollment
357 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

smallpox